Concepedia

Author

Mallion Jm

Centre Hospitalier Universitaire de Grenoble

Also Known As

J M Mallion, J-M Mallion, JM Mallion, Jm. Mallion, Mallion, Mallion J-M, Mallion Jm

65

Publications

3.3K

Citations

11

H-Index

26

Concepts

All Affiliations

Centre Hospitalier Universitaire de GrenobleUniversité Grenoble AlpesHôpital Albert Michallon
MJ

About

Mallion Jm is an author at Centre Hospitalier Universitaire de Grenoble specializing in medicine, hypertension, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

352

2

Public Health

1

1

40

3

Emergency Medicine

1

1

35

4

Global Health

1

1

40

5

Health Policy

1

1

40

Mallion Jm

×

10

Publications

3.2K

Citations

10

H-Index

YearCitations

2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension

Giuseppe Mancia, E. Agabiti Rosei, Renata Cífková,

Lirias (KU Leuven)

2003

2.6K

Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients

J.-P. Baguet, Laure Hammer, Olivier Chabre,

European Journal of Endocrinology

2004

217

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

Mallion Jm, J. P. Siche, Yves Lacourcière

Journal of Human Hypertension

1999

177

Relationships between cardiovascular remodelling and the pulse pressure in never treated hypertension

Baguet Jp, Mallion Jm, A. Moreau-Gaudry,

Journal of Human Hypertension

2000

43

Isolated systolic hypertension: data on a cohort of young subjects from a French working population (IHPAF)

Mallion Jm, L Hamici, Gilles Châtellier,

Journal of Human Hypertension

2003

40

Acceptability and tolerance of ambulatory blood pressure measurement in the hypertensive patient.

Mallion Jm, de Gaudemaris R, J.-P. Baguet,

PubMed

1996

35

Valsartan, a new angiotensin II antagonist; blood pressure reduction in essential hypertension compared with an angiotensin converting enzyme inhibitor, enalapril.

Mallion Jm, S Boutelant, P Chabaux,

PubMed

1997

26

Day and night blood pressure values in normotensive and essential hypertensive subjects assessed by twenty-four-hour ambulatory monitoring.

Mallion Jm, de Gaudemaris R, Siché Jp,

PubMed

1990

20

A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring

J.-P. Baguet, S. Nisse-Durgeat, Stéphane Mouret,

International Journal of Clinical Practice

2006

15

”Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by Valsartan monotherapy”.12 (S1): 36-43; 2003 (1,344)

Mallion Jm, Renzo Carretta, Peter Trenkwalder,

ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)

2003

11

Page 1